1. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
   Abdulmajeed Bahman et al, 2023, BMC Complementary Medicine and Therapies CrossRef
2. Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
   MINORU TOMIZAWA et al, 2014, Oncology Letters CrossRef
3. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents
   Lucas N. Solano et al, 2020, Scientific Reports CrossRef
4. Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine
   Minoru Tomizawa et al, 2017, Oncology Letters CrossRef
5. Short hairpin RNA of frizzled-2 suppresses the proliferation of hepatocellular carcinoma cells
   MINORU TOMIZAWA et al, 2014, Oncology Letters CrossRef
6. In vitro pharmacological, in vivo toxicological and in silico molecular docking analysis of glycopentalone, a novel compound from Glycosmis pentaphylla (Retz.) Correa
   Sreejith P. Sasidharan et al, 2017, Medicinal Chemistry Research CrossRef
7. Targeted Therapy for Advanced Hepatocellular Cancer in the Elderly: Focus on Sorafenib
   D. Germano et al, 2013, Drugs & Aging CrossRef
8. New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
   Kai Qu et al, 2016, Frontiers in Pharmacology CrossRef
9. Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action
   Abdulmajeed Bahman et al, 2018, International Journal of Molecular Medicine CrossRef
10. Sorafenib loaded ZIF-8 metal-organic frameworks as a multifunctional nano-carrier offers effective hepatocellular carcinoma therapy
    Derya Mete et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
11. Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression
    MINORU TOMIZAWA et al, 2015, Oncology Letters CrossRef
12. Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?
    Kai Qu et al, 2016, Oncotarget CrossRef